You just read:

Enzychem Lifesciences Announces Initiation of Global Phase 2 Trial of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)

News provided by

Enzychem Lifesciences, Corp.

Jun 19, 2017, 13:00 ET